Current status of lymph node dissection in pyloric-preserving gastrectomy for early gastric cancer.
10.3760/cma.j.cn441530-20220430-00192
- Author:
Zhi Peng HE
1
;
Yang Yang WANG
1
;
Shi SU
1
;
Ke ZHANG
1
;
Xiao Qi GUAN
1
;
Xiang Huang MEI
2
;
Wei GUO
2
Author Information
1. Department of Surgery, Changzhi Medical College,Changzhi 046000, China.
2. Department of Gastrointestinal Surgery, Heji Hospital Affiliated to Changzhi Medical College, Changzhi 046000, China.
- Publication Type:Journal Article
- MeSH:
Humans;
Pylorus/pathology*;
Stomach Neoplasms/pathology*;
Gastrectomy;
Gastroenterostomy;
Lymph Node Excision
- From:
Chinese Journal of Gastrointestinal Surgery
2023;26(2):202-206
- CountryChina
- Language:Chinese
-
Abstract:
With the gradual increase in the diagnosis rate of early gastric cancer, clinicians must consider prevention of gastric anatomical structure and physiological function while ensuring the radical treatment of the tumor. Pylorus-preserving gastrectomy is a function- preserving operation that preserves the pylorus, inferior pyloric vessel, and the vagus nerve in patients with early middle gastric cancer. One of the major controversies at present is the thoroughness of limited lymph node dissection for pyloric-preserving gastrectomy. Various studies have reported that the lymph node metastasis rate of early middle gastric cancer was low, especially in the suprapyloric region, inferior pylorus and the upper pancreatic region. Partial lymph node dissection is required for vascular and neurological protection, which is also safe and feasible in studies reported by major centers. Many clinical studies have been carried out in Japan and Korea, and postoperative follow-up has gradually increased evidence, providing the basis for the safety of lymph node dissection. In large case studies comparing pylorus- preserving gastrectomy with traditional distal gastrectomy, the incidence of postoperative morbidity, such as dumping syndrome, bile reflux esophagitis, weight loss, and malnutrition is low. Sentinel lymph node navigation technology is gradually applied to the diagnosis and treatment of early gastric cancer, and its clinical application value still needs further research.
